swati girdhar

Author    Correspondence author
International Journal of Clinical Case Reports, 2019, Vol. 9, No. 1   
Received: 05 Jun., 2018    Accepted: 19 Dec., 2018    Published: 29 Jan., 2019

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the present report, a 52-year-old male was diagnosed with Philadelphia chromosome positive CML and treated with imatinib mesylate therapy. He went into morphologic, cytogenetic and molecular remission. After few months of remission, patient developed progressive anemia. On routine hematological investigations, it is pointing towards the diagnosis of chronic lymph proliferative disorder. Clonality of CLL was confirmed by flow cytometry. We described the morphologic, cytogenetic, immunophenotyping, and molecular findings in this patient.

Chronic lymphoid leukemia; Chronic myeloid leukemia; Flow cytometry